Third Harmonic Bio, Inc. (THRD)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
As of 10:28AM EDT. Market open.
| Previous close | 13.26 |
| Open | 13.24 |
| Bid | 12.83 x 200 |
| Ask | 13.35 x 100 |
| Day's range | 13.04 - 13.24 |
| 52-week range | 4.72 - 16.94 |
| Volume | |
| Avg. volume | 148,852 |
| Market cap | 533.981M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
AbbVie (ABBV) Boosts Neuropsychiatric Portfolio With New Deal
AbbVie (ABBV) inks an option-to-license and collaboration deal with Gilgamesh to develop next-generation therapies for psychiatric disorders.
- GuruFocus.com
Insider Sale: CEO Natalie Holles Sells Shares of Third Harmonic Bio Inc (THRD)
Natalie Holles, Chief Executive Officer of Third Harmonic Bio Inc (NASDAQ:THRD), sold 20,222 shares of the company on May 9, 2024.
- GuruFocus.com
Third Harmonic Bio Inc CEO Natalie Holles Sells 13,558 Shares
Natalie Holles, CEO of Third Harmonic Bio Inc (NASDAQ:THRD), has sold 13,558 shares of the company on April 11, 2024, according to a recent SEC Filing.
© 2024 Yahoo. All rights reserved.